ConductScience.org, home

Paper314668

Monoclonal antibodies defining distinctive human T cell surface antigens.

Kung P and 3 others. Science, 1979. Cited by 1,674 papers, by iCite.

Cite this record

ConductScience Library. Monoclonal antibodies defining distinctive human T cell surface antigens. Papers, record 314668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/314668

Download JSON
Cell line
OKT 34 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Monoclonal antibodies defining distinctive human T cell surface antigens.
PubMed
Journal
Science
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,674
iCite
Relative citation ratio, by iCite
40.7
iCite
Revised in PubMed
2021-01-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kung PP
2Goldstein GG
3Reinherz ELE L
4Schlossman SFS F

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, SurfaceMajor topic
T-LymphocytesMajor topic
Animals
Antibody Specificity
Cells, Cultured
Clone Cells
Humans
Leukemia, Experimental
Mice
Plasmacytoma

Source PubMed

Download CSV of topics

Cited by347

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,674 citations.

PMIDTitleJournalYearIn PapersSource
42255261Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia.Blood Neoplasia2026https://conductscience.org/library/papers/42255261PubMed
42156568Realizing the potential of agonistic antibody immunotherapy.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42156568PubMed
42039438CELLISA - a cell-cell binding assay for evaluation of nanovesicle targeting proteins.bioRxiv2026https://conductscience.org/library/papers/42039438PubMed
42003454Taking the biology seriously makes models better.Elife2026https://conductscience.org/library/papers/42003454PubMed
41939869Evaluation of a reference antibody panel for prediction of cytokine release in humanised mouse models in vivo.Front Immunol2026https://conductscience.org/library/papers/41939869PubMed
41367414Integrative and Emerging Models in Antibody Research: A Comprehensive Review.Antib Ther2025https://conductscience.org/library/papers/41367414PubMed
40963254Adoptive transfer of NK cells engineered with a CD5-based chimeric antigen receptor (SRCD5CAR) to treat invasive fungal infections.Mol Ther2025https://conductscience.org/library/papers/40963254PubMed
40634636Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy.Cell Mol Immunol2025https://conductscience.org/library/papers/40634636PubMed
40143120Side Effects of Immunosuppressant Drugs After Liver Transplant.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40143120PubMed
39990653Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence.Int J Biol Sci2025https://conductscience.org/library/papers/39990653PubMed
39584990A Brief Chronicle of Antibody Research and Technological Advances.Antibodies (Basel)2024https://conductscience.org/library/papers/39584990PubMed
39322753Benchmarking algorithms for single-cell multi-omics prediction and integration.Nat Methods2024https://conductscience.org/library/papers/39322753PubMed
39233453Animal models for transplant immunology: bridging bench to bedside.Clin Transplant Res2024https://conductscience.org/library/papers/39233453PubMed
38538786TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.Nature2024https://conductscience.org/library/papers/38538786PubMed
38136728Antibiotic Resistance: Do We Need Only Cutting-Edge Methods, or Can New Visions Such as One Health Be More Useful for Learning from Nature?Antibiotics (Basel)2023https://conductscience.org/library/papers/38136728PubMed
37892982A History and Atlas of the Human CD4+ T Helper Cell.Biomedicines2023https://conductscience.org/library/papers/37892982PubMed
37508539Flow Cytometry: The Next Revolution.Cells2023https://conductscience.org/library/papers/37508539PubMed
36901797Aducanumab-Hope or Disappointment for Alzheimer's Disease.Int J Mol Sci2023https://conductscience.org/library/papers/36901797PubMed
36831533Modulating T Cell Responses by Targeting CD3.Cancers (Basel)2023https://conductscience.org/library/papers/36831533PubMed
35613320An adapted consensus protein design strategy for identifying globally optimal biotherapeutics.MAbs2022https://conductscience.org/library/papers/35613320PubMed

See all 347 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/314668

GET https://conductscience.org/api/papers/v1/314668/cited_by?page=2